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The Baculovirus Expression Vector System (BEVS) is one of the major platforms for recombinant protein 
production and the last decade has become a preferred platform for vaccine development. Unlike mammalian 
expression systems that have long since transitioned to serum-free, chemically-defined culture media, relatively 
little innovation has taken place in insect expression systems, with insect cells continuing to rely on undefined, 
yeastolate-containing culture media that can exhibit significant lot-to-lot variability in terms of both cell growth 
and protein expression.  Here, we present the development of a novel Sf9-based Baculovirus expression 
system based on a high-density, chemically-defined culture medium, a high-expressing Sf9 cell line, improved 
transfection reagent to faster generation of baculoviruses and expression enhancer that allow for consistent 
production of recombinant proteins with two-fold or greater improvements in protein titers compared to 
traditional BEVS workflows.  
 
 
